Portola Pharmaceuticals, Inc. Increase (Decrease) in Inventories
Portola Pharmaceuticals, Inc. reported Increase (Decrease) in Inventories of $15.60 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2020-05-11
- Portola Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2020-03-31 was $15.60M.
- Portola Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2019-12-31 was $61.14M.
- Portola Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2019-09-30 was $552.00K, a 94.26% decline year-over-year.
- Portola Pharmaceuticals, Inc. increase (decrease) in inventories for the quarter ending 2019-06-30 was -$1.37M, a 135.63% decline year-over-year.
- Portola Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2019 was $58.83M, a 366.46% increase from fiscal 2018.
- Portola Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2018 was $12.61M, a 1047.59% increase from fiscal 2017.
- Portola Pharmaceuticals, Inc. increase (decrease) in inventories for fiscal 2017 was $1.10M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2020-03-31 | $15.60M 10-Q · filed 2020-05-11 | $76.74M derived: sum of 2 quarters · filed 2020-05-11 | $77.30M derived: sum of 3 quarters · filed 2020-05-11 | $75.93M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | $61.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $61.69M derived: sum of 2 quarters · filed 2020-02-28 | $60.33M derived: sum of 3 quarters · filed 2020-02-28 | $58.83M 10-K · filed 2020-02-28 |
| 2019-09-30 | $552.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$814.00K derived: sum of 2 quarters · filed 2019-11-05 | -$2.31M 10-Q · filed 2019-11-05 | -$5.30M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | -$1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$2.86M 10-Q · filed 2019-08-07 | -$5.85M derived: sum of 3 quarters · filed 2020-05-11 | $3.77M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-03-31 | -$1.50M 10-Q · filed 2020-05-11 | -$4.48M derived: sum of 2 quarters · filed 2020-05-11 | $5.13M derived: sum of 3 quarters · filed 2020-05-11 | $8.96M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $6.63M derived: sum of 2 quarters · filed 2020-02-28 | $10.46M derived: sum of 3 quarters · filed 2020-02-28 | $12.61M 10-K · filed 2020-02-28 |
| 2018-09-30 | $9.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $13.45M derived: sum of 2 quarters · filed 2019-11-05 | $15.60M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $3.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $5.98M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $2.15M 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $1.10M 10-K · filed 2020-02-28 |